Acutus Medical, Inc. (AFIB)
OTCMKTS · Delayed Price · Currency is USD
0.0410
+0.0020 (5.13%)
Apr 25, 2025, 4:00 PM EDT

Acutus Medical Statistics

Total Valuation

Acutus Medical has a market cap or net worth of 1.22 million. The enterprise value is 22.96 million.

Market Cap 1.22M
Enterprise Value 22.96M

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

Acutus Medical has 29.91 million shares outstanding. The number of shares has increased by 2.31% in one year.

Current Share Class n/a
Shares Outstanding 29.91M
Shares Change (YoY) +2.31%
Shares Change (QoQ) -0.10%
Owned by Insiders (%) 10.02%
Owned by Institutions (%) 0.01%
Float 24.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.06
PB Ratio -0.11
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.41
EV / Sales 1.14
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.72

Financial Position

The company has a current ratio of 2.06

Current Ratio 2.06
Quick Ratio 1.61
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -1.13
Interest Coverage -1.64

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -14.26%
Return on Invested Capital (ROIC) -19.07%
Return on Capital Employed (ROCE) -58.13%
Revenue Per Employee 237,141
Profits Per Employee -112,318
Employee Count 85
Asset Turnover 0.49
Inventory Turnover 6.31

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.42% in the last 52 weeks. The beta is -0.12, so Acutus Medical's price volatility has been lower than the market average.

Beta (5Y) -0.12
52-Week Price Change -75.42%
50-Day Moving Average 0.05
200-Day Moving Average 0.06
Relative Strength Index (RSI) 47.78
Average Volume (20 Days) 28,785

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.02

Income Statement

In the last 12 months, Acutus Medical had revenue of 20.16 million and -9.55 million in losses. Loss per share was -0.32.

Revenue 20.16M
Gross Profit 1.01M
Operating Income -9.42M
Pretax Income -4.54M
Net Income -9.55M
EBITDA -9.13M
EBIT -9.42M
Loss Per Share -0.32
Full Income Statement

Balance Sheet

The company has 14.02 million in cash and 35.76 million in debt, giving a net cash position of -21.75 million or -0.73 per share.

Cash & Cash Equivalents 14.02M
Total Debt 35.76M
Net Cash -21.75M
Net Cash Per Share -0.73
Equity (Book Value) -11.59M
Book Value Per Share -0.39
Working Capital 13.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.66 million and capital expenditures -112,000, giving a free cash flow of -31.77 million.

Operating Cash Flow -31.66M
Capital Expenditures -112,000
Free Cash Flow -31.77M
FCF Per Share -1.06
Full Cash Flow Statement

Margins

Gross margin is 5.03%, with operating and profit margins of -46.75% and -47.36%.

Gross Margin 5.03%
Operating Margin -46.75%
Pretax Margin -22.50%
Profit Margin -47.36%
EBITDA Margin -45.27%
EBIT Margin -46.75%
FCF Margin n/a

Dividends & Yields

Acutus Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.31%
Shareholder Yield -2.31%
Earnings Yield -783.04%
FCF Yield -2,605.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Acutus Medical has an Altman Z-Score of -29.57. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -29.57
Piotroski F-Score n/a